cd30 car-t cell
Cell therapyexperimental
Clinical trial activity
7 trials · 13 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2020 (NCT04268706)
Timeline
Indications
Mechanism of action
- Tumor necrosis factor receptor superfamily member 8Immunity, passive
TNFRSF8 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06617286 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2024 | New York Medical College, University of North Carolina at Chapel Hill |
| NCT05352828 | Phase 1 | Jul 25, 2022 | Baylor University, Bristol-Myers Squibb, Tessa Therapeutics, University of Texas at Houston |
| NCT05208853 | Early Phase 1 (Phase 1) | Feb 10, 2022 | Government of China, Zhejiang University |
| NCT05320081 | Phase 2 | Nov 30, 2021 | Huazhong University of Science and Technology, Nanchang University |
| NCT04526834 | Phase 1 | Nov 30, 2020 | Tessa Therapeutics, University of Texas at Houston |
| NCT04653649 | Phase 1/Phase 2 (Phase 2) | Sep 29, 2020 | Josep Carreras Leukaemia Research Institute, Universidad Carlos III Madrid, University of Barcelona |
| NCT04268706 | Phase 2 | May 1, 2020 | Baylor University, Tessa Therapeutics |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (13)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Tessa Therapeutics | For profit | 3 | 3 | 2 | 2020 |
| Baylor University | Academic/Hospital | 2 | 0 | 2 | 2020 |
| University of Texas at Houston | Academic/Hospital | 2 | 0 | 1 | 2020 |
| Bristol-Myers Squibb | For profit | 1 | 0 | 1 | 2022 |
| Government of China | Government | 1 | 0 | 1 | 2022 |
| Huazhong University of Science and Technology | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Josep Carreras Leukaemia Research Institute | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Nanchang University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| New York Medical College | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Universidad Carlos III Madrid | Academic/Hospital | 1 | 0 | 1 | 2020 |
| University of Barcelona | Academic/Hospital | 1 | 1 | 1 | 2020 |
| University of North Carolina at Chapel Hill | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Zhejiang University | Academic/Hospital | 1 | 1 | 1 | 2022 |
13 organizations
Page 1 / 1